Stay updated with breaking news from Jean smal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MinervaX provides clinical and leadership update Completed enrolment of 150 pregnant women in a Phase 2 study in South Africa and dosing started in an additional 50 pregnant women in Uganda, as part of same study Phase 1 booster study started in the United Kingdom Regulatory approval obtained from Danish Medicines A. ....
/PRNewswire/ MinervaX, a privately held Danish biotechnology company developing a novel vaccine against Group B Streptococcus (GBS), today announces. ....